Resources

Drug services professional

Around half of current injecting drug users will have hepatitis C, although this prevalence rate varies across the country.  Find here tools, resources and other relevant documents to help drugs service staff raise awareness of hepatitis C amongst service users, and improve testing and access to care.

Showing 1 to 10 of 204 resources

  • Hepatitis C: interventions for patient case-finding and linkage to care
    Published in July 2019 this review summarizes the evidence for interventions to increase case-finding and linkage to care for hepatitis C-infected patients, in order to support commissioning and provision of evidence-based interventions as part of efforts to achieve hepatitis C (HCV) elimination as a major public health threat in the UK.
    UK, England, Northern Ireland, Scotland, Wales 30 Jul 2019 Reports & Research PDF
  • Legal Barriers for Providing HCV Community Testing in Europe
    This report from the Correlation European Harm Reduction Network is based on a telephone survey conducted in September and October 2018 with representatives of harm reduction services and NGOs that offer low-threshold services to drug users.
    UK, Rest of World Reports & Research PDF
  • HCV Action & BVHG National Hepatitis C ODN Stakeholder Event: Presentations
    On Thursday 4th July, HCV Action held a National Hepatitis C ODN Stakeholder Event, in partnership with the British Viral Hepatitis Group. The event - HCV Action's biggest to date - brought ODN representatives together to discuss the opportunities and challenges associated with the recently-announced NHS England elimination deal.
    England 30 Jul 2019 Training, Reports & Research, Strategy & Planning PDF
  • Summary report: National Hepatitis C ODN Stakeholder Event
    This report provides a summary of the the breakout sessions held during the HCV Action & British Viral Hepatitis Group National Hepatitis C ODN Stakeholder Event, which took place at the University of Warwick on 4th July 2019. The breakout sessions were held in two parts, the first focusing on problem identification and the second on identifying solutions, and focused on the following topics: community outreach; reaching ethnic minority groups; treating in prisons; and engaging with local commissioners & other partners.
    England 30 Jul 2019 Training, Reports & Research, Strategy & Planning PDF
  • EMCDDA on models of care for hepatitis C in drugs services
    The European Monitoring Centre for Drugs and Drug Addiction published 'Hepatitis C: new models of care for drugs services' in July 2019. This aims to highlight the importance of targeting people who inject drugs as a key population for the elimination of hepatitis C in Europe and to show innovative practice in the form of 11 case studies (three of which are from England). The report provides key insights into the results, impact, sustainability and transferability of each practice to guide the implementation of these new models of care in other countries and settings.
    UK, Rest of World, England, Greater London 29 Jul 2019 Reports & Research, Strategy & Planning PDF
  • Surveillance of hepatitis C testing, diagnosis and treatment in Scotland, 2019 update
    This Health Protection Scotland report outlines that there were 1,423 new diagnoses of hepatitis C antibody-positivity in Scotland in 2018, the lowest number of new hepatitis C antibody diagnoses in Scotland since 1996. It is estimated that approximately 21,000 individuals were living with chronic hepatitis C infection in Scotland by the end of 2018 and approximately 10,500 of these have been diagnosed. A total of 2,609 individuals were initiated onto hepatitis C treatment during financial year 2018/19.
    Scotland 23 Jul 2019 Reports & Research PDF
  • Drug-related infectious diseases in Europe
    This report from the European Monitoring Centre for Drugs and Drug Addiction provides an overview of infectious disease surveillance data, outbreak investigations, and prevention and control measures among people who inject drugs in Europe up to February 2019, including viral hepatitis.
    UK, Rest of World 16 Jul 2019 Reports & Research PDF
  • Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners
    This study evaluates peer-supported screening as a model of active HCV case finding within prisons with a secondary aim to describe the HCV cascade among those infected including linkage to care and treatment outcomes. The study was carried out in a medium-security Irish male prison with over 500 inmates. The authors conclude that peer-supported screening is an effective active HCV case-finding model to find and link prisoners with untreated active HCV infection to HCV care.
    Rest of World 09 Jul 2019 Reports & Research PDF
  • WHO policy brief on access to testing and treatment for people who inject drugs and people in prisons
    The World Health Organisation (WHO) published this policy brief in April 2019 to set out the current landscape of country hepatitis policies for harm reduction and hepatitis C testing and treatment for people who inject drugs and people in prisons. It aims to capture how governments are translating the WHO Global health sector strategy on viral hepatitis 2016-2021, which the UK Government has signed up to, in national plans. It also provides a summary of the enablers and barriers to hepatitis C testing and treatment in these populations.
    UK, Rest of World 17 May 2019 Reports & Research, Tools & Templates, Strategy & Planning PDF
  • Hepatitis C in England 2019 report
    Public Health England's annual report on the UK’s progress towards eliminating hepatitis C sets out that although a lot has been achieved towards the World Health Organisation’s target of eliminating hepatitis C as a major public health threat by 2030, there is still much to do. In particular, the report calls for a 'radical change' in the health service's approach to hepatitis C among people who inject drugs.
    UK 09 Apr 2019 Reports & Research, Strategy & Planning PDF

Pages